What Is FIB-4
FIB-4 often appears when a clinician is checking whether fatty liver, hepatitis, or another chronic liver condition may have led to scarring. It is helpful because it uses labs many people already have. It is also easy to misread. FIB-4 is a screening and risk-stratification score, not a diagnosis of cirrhosis or a confirmed fibrosis stage.
Overview
FIB-4 means Fibrosis-4 Index. It is a unitless score calculated from age, AST, ALT, and platelet count. The formula is: (age x AST) divided by (platelets x the square root of ALT). Platelets are entered in 10^9/L, and AST and ALT are entered in U/L.
The score tries to combine two ideas. Liver-cell irritation can raise AST and ALT. Advanced scarring and portal-pressure changes can be associated with lower platelets. Age also affects the score, which is useful but creates a limitation in younger and older adults.
What This Result Usually Means
A low FIB-4 suggests low risk of advanced fibrosis. A high FIB-4 suggests higher risk and usually leads to second-line assessment such as transient elastography, FibroScan or VCTE, MRE, ELF testing, imaging, or referral to a liver specialist.
The score does not tell the cause. A high result can appear with chronic hepatitis B, hepatitis C, MASLD or MASH, alcohol-related liver disease, or other liver conditions. It also can be lifted by temporary AST changes or by age itself.
Normal Range
FIB-4 is unitless. AASLD guidance commonly uses these bands: below 1.3 is low risk for advanced fibrosis; 1.3 to 2.67 is indeterminate; above 2.67 is high risk. For people older than 65, the low-risk threshold is often adjusted to below 2.0.
Some original validation work used different cutoffs, including below 1.45 and above 3.25. That is why you should use the range printed on your own lab report and the interpretation from your clinician rather than treating a calculator as a final answer.
What A High Result May Mean
Common or reversible reasons for a higher FIB-4 include acute hepatitis, a temporary AST rise, a platelet count that is physiologically lower for you, lab variation, or age over 65 where the standard cutoff can overcall risk.
Medical causes that need follow-up include advanced fibrosis, cirrhosis, chronic hepatitis B or C related fibrosis, advanced MASLD or MASH, and alcohol-related liver disease. A high result does not confirm any of these. It means the next test should be more specific to liver stiffness or liver structure.
What A Low Result May Mean
A low FIB-4 usually means low risk of advanced fibrosis. That is useful because it can help many people avoid unnecessary invasive testing when the rest of the clinical picture fits.
Low is not the same as no liver issue. Young adults may have falsely low scores because age is part of the formula. A high platelet count or low AST can also pull the score down. If fatty liver is seen on imaging, or if hepatitis or other liver disease is present, doctors may still monitor over time.
Related Lab Tests To Check Together
FIB-4 depends on AST, ALT, and platelets, so start there. APRI is another simple score based on AST and platelets. Albumin, bilirubin, PT/INR, ALP, and GGT show whether the liver pattern involves bile flow or synthetic function.
Elastography is the usual next step when FIB-4 is unclear or high. FibroScan or VCTE and MRE estimate stiffness. Imaging can show liver shape, spleen size, or other clues. Biopsy remains a reference standard in selected cases, but it is not the first step for every person.
Why Trends Matter More Than One Result
FIB-4 can change because AST, ALT, or platelets change. A single score from a day when AST was temporarily high may look more concerning than your usual baseline.
Repeated scores are more useful. If FIB-4 remains below the low-risk cutoff, that is different from a score that rises from low to indeterminate and then high. Tracking the underlying labs lets your doctor see which part of the formula is driving the change.
When To Talk With A Doctor
Talk with a doctor if your FIB-4 is 1.3 or higher, if it is rising, if platelets are falling, or if bilirubin, albumin, or INR are abnormal. Also discuss it if you have hepatitis B, hepatitis C, fatty liver disease, heavy alcohol exposure, diabetes, high triglycerides, high blood pressure, or prior liver imaging abnormalities.
Seek timely care if liver-related labs are paired with jaundice, dark urine, confusion, black stools, vomiting blood, new abdominal swelling, or severe abdominal pain.
Frequently Asked Questions
What is FIB-4 score? FIB-4 is a unitless screening score that estimates the risk of advanced liver fibrosis using age, AST, ALT, and platelets.
How is FIB-4 calculated? The formula is (age x AST) divided by (platelets x the square root of ALT), using AST and ALT in U/L and platelets in 10^9/L.
What is a low FIB-4? Below 1.3 is commonly considered low risk for advanced fibrosis, while people older than 65 often use below 2.0 as the low-risk threshold.
What is a high FIB-4? Above 2.67 is commonly treated as high risk and usually needs second-line testing or specialist review.
What does a FIB-4 between 1.3 and 2.67 mean? That is an indeterminate zone. It usually means the score alone cannot answer the fibrosis question.
Can FIB-4 diagnose cirrhosis? No. FIB-4 is a screening and risk-stratification tool, not a stand-alone diagnosis of cirrhosis or fibrosis stage.
Why does age affect FIB-4? Age is part of the formula, so older age can raise the score and younger age can lower it even when the same AST, ALT, and platelet values are used.
What comes after a high FIB-4? Doctors often use elastography such as FibroScan or VCTE, MRE, ELF testing, imaging, or specialist evaluation.
How MediLens Helps Track This Over Time
FIB-4 is built from moving parts. MediLens helps you scan reports and keep AST, ALT, platelets, and the score in one place. Instead of saving disconnected PDFs, you can see whether the score is stable and which lab value is changing. That makes follow-up visits more focused.
Key Takeaways
- FIB-4 uses age, AST, ALT, and platelets to estimate fibrosis risk.
- Below 1.3 is commonly low risk, 1.3 to 2.67 is indeterminate, and above 2.67 is high risk.
- For people older than 65, below 2.0 is often used as the low-risk threshold.
- FIB-4 is screening, not diagnosis; elastography, imaging, or biopsy may be needed.
- Trends and the underlying AST, ALT, and platelet values matter more than one score.
This article is for general education, based on AASLD liver disease guidance and the ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. It is not a diagnosis or treatment advice and does not replace your doctor. Interpret results using the reference ranges on your own lab report and your physician's guidance.
A single lab result only tells part of the story. MediLens helps you scan lab reports, organize your results, compare changes over time, and better understand your long-term health trends.